Business Description
Prince Pharmaceutical Co Ltd
ISIN : TW0006935000
Total Employee Number:
216Description
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | 2.4 | |||||
Interest Coverage | 11.57 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.27 | |||||
Beneish M-Score | -2.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.4 | |||||
3-Year EBITDA Growth Rate | 8.4 | |||||
3-Year EPS without NRI Growth Rate | 18.9 | |||||
3-Year FCF Growth Rate | -3.5 | |||||
3-Year Book Growth Rate | 7.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 52.42 | |||||
9-Day RSI | 51.77 | |||||
14-Day RSI | 51.28 | |||||
3-1 Month Momentum % | 2.25 | |||||
6-1 Month Momentum % | -2.31 | |||||
12-1 Month Momentum % | 17.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.81 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 75.89 | |||||
Days Sales Outstanding | 44.75 | |||||
Days Payable | 55.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.66 | |||||
Forward Dividend Yield % | 1.66 | |||||
5-Year Yield-on-Cost % | 1.65 | |||||
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 3.28 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.07 | |||||
Operating Margin % | 10.5 | |||||
Net Margin % | 9.12 | |||||
EBITDA Margin % | 16.66 | |||||
FCF Margin % | 6.75 | |||||
OCF Margin % | 8.53 | |||||
ROE % | 12.56 | |||||
ROA % | 6.86 | |||||
ROIC % | 9.24 | |||||
3-Year ROIIC % | -391.34 | |||||
ROC (Joel Greenblatt) % | 10.75 | |||||
ROCE % | 10.03 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 11.55 | |||||
PE Ratio without NRI | 11.55 | |||||
Price-to-Owner-Earnings | 18.72 | |||||
PS Ratio | 1.04 | |||||
PB Ratio | 1.34 | |||||
Price-to-Tangible-Book | 1.35 | |||||
Price-to-Free-Cash-Flow | 15.6 | |||||
Price-to-Operating-Cash-Flow | 12.34 | |||||
EV-to-EBIT | 12.22 | |||||
EV-to-EBITDA | 7.94 | |||||
EV-to-Revenue | 1.32 | |||||
EV-to-FCF | 19.69 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Graham-Number | 0.83 | |||||
Earnings Yield (Greenblatt) % | 8.18 | |||||
FCF Yield % | 6.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prince Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,056.201 | ||
| EPS (TTM) (NT$) | 2.61 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.26 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 38.01 | ||
| 14-Day RSI | 51.28 | ||
| 14-Day ATR (NT$) | 1.271679 | ||
| 20-Day SMA (NT$) | 29.945 | ||
| 12-1 Month Momentum % | 17.26 | ||
| 52-Week Range (NT$) | 24.25 - 35.85 | ||
| Shares Outstanding (Mil) | 37.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prince Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prince Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.500000 Cash Dividend | 2026-07-01 | 29.80 (+0.00%) |
Show
Entries
Prince Pharmaceutical Co Ltd Frequently Asked Questions
What is Prince Pharmaceutical Co Ltd(ROCO:6935)'s stock price today?
The current price of ROCO:6935 is NT$30.15. The 52 week high of ROCO:6935 is NT$35.85 and 52 week low is NT$24.25.
When is next earnings date of Prince Pharmaceutical Co Ltd(ROCO:6935)?
The next earnings date of Prince Pharmaceutical Co Ltd(ROCO:6935) is .
Does Prince Pharmaceutical Co Ltd(ROCO:6935) pay dividends? If so, how much?
The Dividend Yield %  of Prince Pharmaceutical Co Ltd(ROCO:6935) is 1.66% (As of Today), Highest Dividend Payout Ratio of Prince Pharmaceutical Co Ltd(ROCO:6935) was 0.36. The lowest was 0.36. And the median was 0.36. The  Forward Dividend Yield % of Prince Pharmaceutical Co Ltd(ROCO:6935) is 1.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Prince Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers